2020
Eskes C, Corsini E, Hanley V, Karadjova I, Kopp-Schneider A, Suh M , Alves P, Clewell R, et al. 2020. ESAC opinion on the scientific validity of the bioelution test method. In: Viegas Barroso J (ed), EUR 30281 EN . Publications Office of the European Union, Luxembourg, ISBN 978-92-76-20004-8 (online), doi:10.2760/023005 (online), JRC121143.
View Abstract
Publication: Report
2019
Patlewicz G , Richard AM, Williams AJ, Grulke CM, Sams R, Lambert J, Noyes P, DeVito MJ, et al. 2019. A chemical category-based prioritization approach for selecting 75 per- and polyfluoroalkyl substances (PFAS) for tiered toxicity and toxicokinetic testing. Environ Health Perspect 127(1):14501; doi: 10.1289/EHP4555 . PMID: 30632786.
View Abstract
Publication: Manuscripts
2018
Klaren WD , Rusyn I. 2018. High-content assay multiplexing for muscle toxicity screening in human-induced pluripotent stem cell-derived skeletal myoblasts. Assay Drug Dev Technol 16(6):333–342; doi: 10.1089/adt.2018.86 . PMID: 30070899.
View Abstract
Publication: Manuscripts
2017
Iwata Y, Klaren WD , Lebakken CS, Grimm FA, Rusyn I. 2017. High-content assay multiplexing for vascular toxicity screening in induced pluripotent stem cell-derived endothelial cells and human umbilical vein endothelial cells. Assay Drug Dev Technol 15(6):267–279; doi: 10.1089/adt.2017.786 . PMID: 28771372.
View Abstract
Publication: Manuscripts
2016
Klaren WD , Iwata Y, Lebakken CS, Grimm FA, Rusyn I. High-content assay multiplexing for vascular toxicity screening in induced pluripotent stem cell-derived endothelial cells and human umbilical vein endothelial cells. College of Veterinary Medicine Graduate Student and Postdoc Research Symposium, Texas A&M University, 2016.
Publication: Abstracts and Presentations
2010
Daston GP, Chapin R, Scialli AR, Piersma AH, Carney EW, Rogers JM , Friedman JM. 2010. A different approach to validating screening assays for developmental toxicity. Birth Defects Res B 89(6):526–530. doi: 10.1002/bdrb.20276 . PMID: 21086491.
View Abstract